Boehringer Ingelheim: Accelerating Clinical Trials with a Unified Clinical Platform
"Collaboration between data management and clinical operations has always been important, but it was never truly supported by technology. Now, we have a platform that facilitates that collaboration."
Boehringer Ingelheim made a strategic shift to a unified clinical platform. Moving away from a heavy outsourcing model, they strengthened end-to-end oversight and operational flexibility across clinical operations and clinical data management. Implementing the One Medicine Platform, powered by the Veeva Clinical Platform, Boehringer Ingelheim streamlined processes and empowered teams to rethink cross-functional workflows. Consolidating its technology stack, they established a single source of truth that reduces the administrative burden on both internal teams and clinical research sites.
Discover how this unified approach helps Boehringer Ingelheim accelerate trial timelines and deliver treatments to patients more efficiently.
